Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

• DOI: 10.1038/s41375-021-01333-y
• Publication Date: 2021-07-01T16:06:50Z
• Authors: Judith M. Boer; Maria Grazia Vals...; Femke M. Hormann; Željko Antić; Marketa Zaliova; Claire Schwab; Giovanni Cazzaniga; Chloé Arfeuille; Hélène Cavé; Andishe Attarbaschi; Sabine Strehl; Gabriele Escherich; Toshihiko Imamura; Kentaro Ohki; Tanja A. Grüber; Rosemary Sutton; Agata Pastorczak; Tim Lammens; Frédéric Lambert; Chi Kong Li; Enrique Carrillo ...; Steve Hoffmann; Anja Möricke; Christine J. Harr...; Monique L. Den Boer; Paola De Lorenzo; Ronald W. Stam; Anke K. Bergmann; Rob Pieters
• Keywords: Male; Cancer Research; Letter; Childhood Leukemia; Pediatric Cancer; anzsrc-for: 3211 Oncology and carcinogenesis; 610; 32 Biomedical and Clinical Sciences; anzsrc-for: 1103 Clinical Sciences; 618; 03 medical and health sciences; Rare Diseases; anzsrc-for: 32 Biomedical and Clinical Sciences; 0302 clinical medicine; SDG 3 - Good Health and Well-being; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Medicine and Health Sciences; Humans; Child; Cancer; Pediatric; Gene Rearrangement; INTENSIFICATION; anzsrc-for: 3201 Cardiovascular Medicine and Haematology; anzsrc-for: 1112 Oncology and Carcinogenesis; Infant; Nuclear Proteins; Hematology; Prognosis; Neoplasm Proteins; Survival Rate; Anesthesiology and Pain Medicine; 3201 Cardiovascular Medicine and Haematology; anzsrc-for: 3202 Clinical sciences; Female